Copyright
©The Author(s) 2024.
World J Clin Cases. May 16, 2024; 12(14): 2324-2331
Published online May 16, 2024. doi: 10.12998/wjcc.v12.i14.2324
Published online May 16, 2024. doi: 10.12998/wjcc.v12.i14.2324
Table 1 Comparison of demographic data between the groups, n (%)
| Variables | No recurrent, n = 252 | Recurrent, n = 51 | P value |
| DM | 0.038 | ||
| Absence | 215 (85.3) | 37 (72.5) | |
| Presence | 37 (14.7) | 14 (27.5) | |
| HT | 0.012 | ||
| Absence | 159 (63) | 22 (43.1) | |
| Presence | 93 (37) | 29 (56.9) | |
| KAD | 0.707 | ||
| Absence | 200 (79.3) | 39 (76.5) | |
| Presence | 52 (20.7) | 12 (23) | |
| Lung pathologies | 0.211 | ||
| Absence | 228 (90.4) | 43 (84.3) | |
| Presence | 24 (9.6) | 8 (15.7) | |
| Comorbidity | 0.013 | ||
| Absence | 121 (48) | 15 (29.5) | |
| One comorbidity | 59 (23.4) | 11 (21.5) | |
| More than one comorbidity | 72 (28.6) | 25 (49) | |
| Primary cause | 0.071 | ||
| Iatrogenic | 87 (34.6) | 26 (60) | |
| Trauma | 13 (5.1) | 4 (7.9) | |
| Post-inflamatuar | 4 (1.6) | 0 (0) | |
| Idiopatic | 148 (58.7) | 21 (41.1) | |
| Cause of iatrojenic | 0.488 | ||
| RP | 12 (13.8) | 5 (19.3) | |
| RT | 12 (13.8) | 4 (15.3) | |
| Others | 53 (60.9) | 12 (46.1) | |
| RP+RT | 10 (11.5) | 5 (19.3) | |
| Stricture localization | 0.707 | ||
| Penile | 25 (10) | 6 (11.8) | |
| Bulbar | 136 (54) | 29 (56.9) | |
| Bulbomembranous | 18 (7.2) | 2 (3.9) | |
| Membranous | 8 (3.1) | 0 (0) | |
| Prostatic urethra | 7 (2.7) | 0 (0) | |
| Bladder neck | 23 (9.1) | 8 (15.6) | |
| Panurethral | 8 (3.2) | 1 (2) | |
| More than one | 27 (10.7) | 5 (9.8) | |
| Postoperative NSAII administration | 0.758 | ||
| Absence | 140 (55.5) | 30 (58.8) | |
| Presence | 112 (44.5) | 21 (41.2) | |
| Preoperative cystostomy | 0.764 | ||
| Absence | 235 (93.2) | 47 (92.1) | |
| Presence | 17 (6.8) | 4 (7.9) | |
| Blood group | 0.405 | ||
| A+ | 110 (43.7) | 23 (45) | |
| A- | 18 (7.1) | 1 (2) | |
| B+ | 22 (8.8) | 3 (5.9) | |
| B- | 6 (2.3) | 1 (2) | |
| AB+ | 21 (8.4) | 3 (5.9) | |
| AB- | 3 (1.2) | 3 (5.9) | |
| 0+ | 66 (26.2) | 16 (31.3) | |
| 0- | 6 (2.3) | 1 (2) | |
| Scricture lenght | 0.196 | ||
| < 1 cm | 76 (30.1) | 9 (17.7) | |
| 1-2 cm | 154 (61.1) | 39 (76.4) | |
| 2-4 cm | 10 (4) | 2 (3.9) | |
| > 4 cm | 12 (4.8) | 1 (2) | |
| Postoperative inserted indwelling urinary catheter size | 0.809 | ||
| 16 Fr | 25 (10) | 4 (7.8) | |
| 18 Fr | 105(41.6) | 24 (47.1) | |
| 20 Fr | 122 (48.4) | 23 (45.1) | |
| Catheter removal day | 0.765 | ||
| < 3 d | 10 (4) | 2 (4) | |
| 3-5 d | 61 (24.2) | 10 (19.6) | |
| > 5 d | 181 (71.8) | 39 (76.4) |
Table 2 Comparison of data between groups
| Variables (median-IQR) | No recurrent, n = 252 | Recurrent, n = 51 | P value |
| Age (yr) | 70 (62-75) | 68 (61-71) | 0.109 |
| Qmax (mL/sn) | 6 (4-7) | 6 (3.5-8) | 0.800 |
| Hgb (g/dL) | 13.8 (12.4-14.7) | 13.8 (12.8-14.7) | 0.987 |
| Hct | 41.7 (37.7-44.4) | 41 (38.8-43.8) | 0.769 |
| Leukocyte (103/µL) | 7.4 (6.2-9.3) | 7.1 (6.3-8.6) | 0.501 |
| Neutrophil (103/µL) | 4.7 (3.7-6) | 4.5 (3.6-5.6) | 0.444 |
| Lymphocyte (103/µL) | 1.9 (1.5-2.4) | 1.7 (1.4-2.3) | 0.558 |
| Platelet (103/µL) | 251 (207-303) | 241 (214-297) | 0.789 |
| Monocyte (103/µL) | 0.5 (0.4-0.6) | 0.5 (0.3-0.7) | 0.509 |
| AST (U/L) | 17 (14-20) | 17 (13-21) | 0.421 |
| ALT (U/L) | 15 (11-21) | 16 (12-22) | 0.467 |
| Glucose (mg/dL) | 101 (89-118) | 98 (84-116) | 0.369 |
| Creatinine (mg/dL) | 0.9 (0.8-1.1) | 1 (0.9-1.1) | 0.209 |
| GFR (mL/mn) | 82 (64-93) | 80 (71-89) | 0.613 |
| NLR | 2.4 (1.8-3.4) | 2.3 (1.7-3.6) | 0.743 |
| PLR | 126 (99-173) | 131(96-183) | 0.711 |
| LMR | 3.8 (2.9-4.7) | 3.4 (2.4-4.8) | 0.393 |
| MLR | 0.2 (0.2-0.3) | 0.2 (0.2-0.4) | 0.393 |
| De ritis ratio | 1 (0.8-1.4) | 1 (0.8-1.2) | 0.259 |
- Citation: Gul A, Ekici O, Zengin S, Barali D, Keskin T. Investigation of risk factors in the development of recurrent urethral stricture after internal urethrotomy. World J Clin Cases 2024; 12(14): 2324-2331
- URL: https://www.wjgnet.com/2307-8960/full/v12/i14/2324.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i14.2324